Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Diabetes and cancer.

Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R.

Endocr Relat Cancer. 2009 Dec;16(4):1103-23. doi: 10.1677/ERC-09-0087. Epub 2009 Jul 20. Review.

PMID:
19620249
[PubMed - indexed for MEDLINE]
Free Article
2.

[Molecular action of insulin-sensitizing agents].

Kacalska O, Krzyczkowska-Sendrakowska M, Milewicz T, Zabińska-Popiela M, Bereza T, Krzysiek-Maczka G, Krzysiek J.

Endokrynol Pol. 2005 May-Jun;56(3):308-13. Review. Polish.

PMID:
16350724
[PubMed - indexed for MEDLINE]
3.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
[PubMed - indexed for MEDLINE]
4.

Diabetes and cancer: is diabetes causally related to cancer?

Suh S, Kim KW.

Diabetes Metab J. 2011 Jun;35(3):193-8. doi: 10.4093/dmj.2011.35.3.193. Epub 2011 Jun 30.

PMID:
21785737
[PubMed]
Free PMC Article
5.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
[PubMed - indexed for MEDLINE]
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
7.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
8.

[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].

Ozawa H, Murai Y, Ozawa T.

Yakushigaku Zasshi. 2003;38(1):11-27. Japanese.

PMID:
14570054
[PubMed - indexed for MEDLINE]
9.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
[PubMed - indexed for MEDLINE]
10.

Diabetes mellitus type 2 - an independent risk factor for cancer?

Grote VA, Becker S, Kaaks R.

Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):4-8. doi: 10.1055/s-0029-1243193. Epub 2010 Feb 1. Review.

PMID:
20127570
[PubMed - indexed for MEDLINE]
11.

Diabetes and pancreatic cancer.

Cui Y, Andersen DK.

Endocr Relat Cancer. 2012 Sep 5;19(5):F9-F26. doi: 10.1530/ERC-12-0105. Print 2012 Oct. Review.

PMID:
22843556
[PubMed - indexed for MEDLINE]
Free Article
13.

Epidemiological aspects of neoplasms in diabetes.

Nicolucci A.

Acta Diabetol. 2010 Jun;47(2):87-95. doi: 10.1007/s00592-010-0187-3. Epub 2010 Apr 8. Review.

PMID:
20376506
[PubMed - indexed for MEDLINE]
14.

Exercise and diabetes.

Chipkin SR, Klugh SA, Chasan-Taber L.

Cardiol Clin. 2001 Aug;19(3):489-505. Review.

PMID:
11570119
[PubMed - indexed for MEDLINE]
15.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
[PubMed - indexed for MEDLINE]
16.

Energy balance, physical activity, and cancer risk.

Fair AM, Montgomery K.

Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Review.

PMID:
19107429
[PubMed - indexed for MEDLINE]
17.

Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.

Yamagishi S, Nakamura K, Inoue H, Kikuchi S, Takeuchi M.

Med Hypotheses. 2005;64(6):1208-10.

PMID:
15823719
[PubMed - indexed for MEDLINE]
18.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
[PubMed - indexed for MEDLINE]
19.

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.

Resmini E, Minuto F, Colao A, Ferone D.

Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Review.

PMID:
19322513
[PubMed - indexed for MEDLINE]
20.

Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.

Stefanović V, Antić S.

Clin Lab. 2004;50(5-6):271-8. Review.

PMID:
15209435
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk